Targeting mast cells restores T cell infiltration and sensitizes sarcomas to PD-L1 inhibition.

被引：0
|
作者：
Panagi, Myrofora [1 ]
Mpekris, Fotios [1 ]
Voutouri, Chrysovalantis [1 ]
Michael, Christina [1 ]
Constantinidou, Anastasia [2 ]
Martin, John D. [3 ]
Stylianopoulos, Triantafyllos [1 ]
机构：
[1] Univ Cyprus, Nicosia, Cyprus
[2] Bank Cyprus Oncol Ctr, Nicosia, Cyprus
[3] Innovat Ctr Nanomed, Tokyo, Japan
来源：
CANCER RESEARCH | 2022年 / 82卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6382
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Stabilizing Tumor-Resident Mast Cells Restores T-Cell Infiltration and Sensitizes Sarcomas to PD-L1 Inhibition
    Panagi, Myrofora
    Mpekris, Fotios
    Voutouri, Chrysovalantis
    Hadjigeorgiou, Andreas G.
    Symeonidou, Chloe
    Porfyriou, Eleni
    Michael, Christina
    Stylianou, Andreas
    Martin, John D.
    Cabral, Horacio
    Constantinidou, Anastasia
    Stylianopoulos, Triantafyllos
    CLINICAL CANCER RESEARCH, 2024, 30 (11) : 2582 - 2597
  • [2] Inhibition of ATR downregulates PD-L1 and sensitizes tumor cells to T cell-mediated killing
    Sun, Lin-Lin
    Yang, Ri-Yao
    Li, Chia-Wei
    Chen, Mei-Kuang
    Shao, Bin
    Hsu, Jung-Mao
    Chan, Li-Chuan
    Yang, Yi
    Hsu, Jennifer L.
    Lai, Yun-Ju
    Hung, Mien-Chie
    AMERICAN JOURNAL OF CANCER RESEARCH, 2018, 8 (07): : 1307 - +
  • [3] Correlation of T-cell infiltration and clonality with PD-L1 expression in soft tissue sarcomas.
    Pollack, Seth
    He, Qianchuan
    Yearley, Jennifer
    Emerson, Ryan O.
    Vignali, Marissa
    Zhang, Yuzheng
    Redman, Mary
    Loggers, Elizabeth Trice
    Cranmer, Lee D.
    Pillarisetty, Venu Gopal
    Ricciotti, Robert
    Hoch, Benjamin L.
    Murphy, Erin
    McClanahan, Terrill K.
    Blumenschein, Wendy
    Townson, Steven Matthew
    Benzeno, Sharon
    Riddell, Stanley R.
    Jones, Robin Lewis
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (07)
  • [4] Targeting PD-L1 sensitizes head and neck squamous cell carcinoma to cisplatin
    Qiao, Peter
    Lajud, Shayanne A.
    Nagda, Danish A.
    Tanaka, Nobuaki
    Civantos, Alyssa
    O'Malley, Bert W.
    Li, Daqing
    CANCER RESEARCH, 2014, 74 (19)
  • [5] Pharmaceutical targeting of OTUB2 sensitizes tumors to cytotoxic T cells via degradation of PD-L1
    Ren, Wenfeng
    Xu, Zilong
    Chang, Yating
    Ju, Fei
    Wu, Hongning
    Liang, Zhiqi
    Zhao, Min
    Wang, Naizhen
    Lin, Yanhua
    Xu, Chenhang
    Chen, Shengming
    Rao, Yipeng
    Lin, Chaolong
    Yang, Jianxin
    Liu, Pingguo
    Zhang, Jun
    Huang, Chenghao
    Xia, Ningshao
    NATURE COMMUNICATIONS, 2024, 15 (01)
  • [6] Pharmaceutical targeting of OTUB2 sensitizes tumors to cytotoxic T cells via degradation of PD-L1
    Wenfeng Ren
    Zilong Xu
    Yating Chang
    Fei Ju
    Hongning Wu
    Zhiqi Liang
    Min Zhao
    Naizhen Wang
    Yanhua Lin
    Chenhang Xu
    Shengming Chen
    Yipeng Rao
    Chaolong Lin
    Jianxin Yang
    Pingguo Liu
    Jun Zhang
    Chenghao Huang
    Ningshao Xia
    Nature Communications, 15
  • [7] Targeting B7-H1 (PD-L1) sensitizes cancer cells to chemotherapy
    Wu, Xiaosheng
    Li, Yanli
    Liu, Xin
    Chen, Chunhua
    Harrington, Susan M.
    Cao, Siyu
    Xie, Tiancheng
    Orzechowski, Amanda
    Tu Pham
    Mansfield, Aaron S.
    Yan, Yiyi
    Kwon, Eugene D.
    Wang, Liewei
    Ling, Kun
    Dong, Haidong
    HELIYON, 2018, 4 (12):
  • [8] Classifying Cancers Based on T-cell Infiltration and PD-L1
    Teng, Michele W. L.
    Ngiow, Shin Foong
    Ribas, Antoni
    Smyth, Mark J.
    CANCER RESEARCH, 2015, 75 (11) : 2139 - 2145
  • [9] Beyond inhibition against the PD-1/PD-L1 pathway: development of PD-L1 inhibitors targeting internalization and degradation of PD-L1
    Guo, Jiazheng
    Yu, Fengyi
    Zhang, Kuojun
    Jiang, Sheng
    Zhang, Xiangyu
    Wang, Tianyu
    RSC MEDICINAL CHEMISTRY, 2024, 15 (04): : 1096 - 1108
  • [10] Targeting regulatory T cells in anti-PD-1/PD-L1 cancer immunotherapy
    Zhulai, Galina
    Oleinik, Eugenia
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2022, 95 (03)
12345